Welcome to LookChem.com Sign In|Join Free

CAS

  • or

37858-07-4

Post Buying Request

37858-07-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

37858-07-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 37858-07-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,8,5 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 37858-07:
(7*3)+(6*7)+(5*8)+(4*5)+(3*8)+(2*0)+(1*7)=154
154 % 10 = 4
So 37858-07-4 is a valid CAS Registry Number.

37858-07-4Relevant articles and documents

COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER

-

Page/Page column 35; 37; 39-40, (2021/02/26)

The invention provides the imidazole, oxazole and thiazole compounds and use thereof in methods for treating a disease or a disorder, such as infectious diseases and cancer, wherein inhibition of sphingosine-1-phosphate lyase is beneficial to treat the disease or the disorder.

Structure-property relationship study of n-(hydroxy)peptides for the design of self-assembled parallel β-sheets

Roche, Stéphane P.,Richaud, Alexis D.

, p. 12329 - 12342 (2020/11/10)

The design of novel and functional biomimetic foldamers remains a major challenge in creating mimics of native protein structures. Herein, we report the stabilization of a remarkably short β-sheet by incorporating N-(hydroxy)glycine (Hyg) residues into the backbone of peptides. These peptide- peptoid hybrids form unique parallel β-sheet structures by selfassembly upon hydrogenation. Our spectroscopic and crystallographic data suggest that the local conformational perturbations induced by N-(hydroxy)amides are outweighed by a network of strong interstrand hydrogen bonds.

In vitro and in silico evaluation of non-quaternary reactivators of AChE as antidotes of organophosphorus poisoning - A new hope or a blind alley?

Soukup, Ondrej,Korabecny, Jan,Malinak, David,Nepovimova, Eugenie,Pham, Ngoc L.,Musílek, Kamil,Hrabinova, Martina,Hepnarova, Vendula,Dolezal, Rafael,Pavek, Petr,Jost, Petr,Kobrlova, Tereza,Jankockova, Jana,Gorecki, Lukas,Psotka, Miroslav,Nguyen, Thuy D.,Box, Karl,Outhwaite, Breeze,Ceckova, Martina,Sorf, Ales,Jun, Daniel,Kuca, Kamil

, p. 281 - 292 (2018/05/17)

Background: In the last decade, the concept of uncharged reactivators potentially able to penetrate the CNS has been introduced as an alternative to the classic charged oxime reactivators. However, this concept brings with it several associated drawbacks

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 37858-07-4